The 20 Best Neurocutaneous Melanosis Doctors Near Me in Ann Arbor, MI

A Craig is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Craig is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Neurocutaneous Melanosis, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Melanocytic Nevus.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringoma, and Syringocystadenoma Papilliferum. Dr. Lowe is board certified in Dermatology and Dermatopathology.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

Dr. Jennifer Schwartz received her medical degree from Northwestern University Medical School and completed her internship in internal medicine at Northwestern Medical Center in Chicago. She completed her dermatology residency at the University of Michigan Department of Dermatology and two years of specialty training in melanoma at the U-M Rogel Cancer Center.Additionally, she completed advanced specialty training in cutaneous surgery treatment of benign and malignant lesions at the University of Michigan. In 1999, Dr. Schwartz became a faculty member of the Melanoma and Cutaneous Oncology and Surgery Program. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Melanoma, Eccrine Porocarcinoma, Squamous Cell Skin Carcinoma, and Merkel Cell Carcinoma. Dr. Schwartz is board certified in Dermatology.

Dr. Tejasvi received his medical degree from Karnataka Institute of Medical Sciences, India. He completed residency-training program and worked as senior resident in Dermatology and Venereology, from All India Institute of Medical Sciences, New Delhi, India. He completed post-doctoral training in genetics of psoriasis under the direction of Drs. R.P.Nair and James T. Elder at the University of Michigan, Department of Dermatology in Ann Arbor.Dr. Tejasvi's primary research interest is translational genetics, epigenetics in psoriasis and pharmacogenetics that involves application of genetic information to predict response to therapies. Dr. Tejasvi is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis.

Elizabeth Spratt is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Spratt is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Melanoma, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

Thy Do is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Do is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Psoriasis, Warts, and Syringocystadenoma Papilliferum.

Shivani Patel is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Seborrheic Keratosis, and Sunburn.

Katherine Fontichiaro is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Fontichiaro is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. Her clinical expertise encompasses Actinic Keratosis, Warts, Syringoma, and Sebaceous Adenoma.

Dr. Patricia Robertson, M.D., earned a medical degree at Wayne State University Medical School in Detroit and completed a residency in pediatrics at Children's Hospital of Michigan. She then went on to a fellowship in pediatric neurology at the University of Michigan and trained in pediatric neuro-oncology at New York University Medical Center. Dr. Robertson joined the University of Michigan faculty in 1988. She has a special interest in clinical pediatric neuro-oncology focusing on the evaluation of response, outcome and late effects on the developing nervous system; current treatment strategies for children with central nervous malignancies; and in the development of innovative treatment approaches for this population. Dr. Robertson is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 42 other conditions, according to our data. Her clinical expertise encompasses Glioma, Diencephalic Syndrome, Brain Stem Cancer, and Brain Tumor.

Aleodor Andea is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Andea is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Tieche-Jadassohn Nevus, Melanoma, Syringoma, and Basal Cell Skin Cancer.

Dr. Milad Eshaq, Clinical Associate Professor of Dermatology, is a board-certified dermatologist and fellowship-trained Mohs surgeon in the University of Michigan Department of Dermatology. He provides patient care in our Cutaneous Surgery and Oncology outpatient clinic at the Rogel Cancer Center as well as the Domino’s Farms Dermatology Clinic. In addition, Dr. Eshaq provides state-of-the-art cosmetic dermatology procedures and laser treatment within the Cosmetic Dermatology & Laser Center.Dr. Eshaq received his medical degree from the Medical College of Wisconsin in Milwaukee, Wisconsin. He completed his transitional year at Henry Ford Health System in Detroit, Michigan, and his dermatology residency at the University of Michigan, serving as Chief Resident during his final year. Dr. Eshaq joined the dermatology faculty at Michigan Medicine in 2017, serving as Chief of Medical Dermatology and Ambulatory Care Clinical Chief for Dermatology from 2019-2023. He completed a clinical fellowship in Micrographic Surgery & Dermatologic Oncology at Michigan Medicine during 2024 and was appointed as Clinical Associate Professor of Dermatology in 2025. Dr. Eshaq is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Melanoma, Bullous Pemphigoid, Actinic Keratosis, and Hidradenitis Suppurativa. Dr. Eshaq is board certified in Dermatology.

Dr. Yolanda Helfrich is a clinical professor of dermatology and the residency program director of the Department of Dermatology at the University of Michigan Medical School.Dr. Helfrich’s primary clinical focus is on medical dermatology. She has a special interest in rosacea, and has been invited to speak and write nationally about the pathogenesis and treatment of rosacea. She serves on the National Rosacea Society Medical Advisory Board. She also has a clinical specialization in the follow-up and diagnosis of high-risk skin cancer patients and runs a specialty clinic devoted to the care of patients with alopecia (hair loss).Throughout her career, Dr. Helfrich has had a strong interest in clinical research, and served as the Director of the Program for Clinical Research in Dermatology (PCRiD) in the department for 12 years. She has served as Primary Investigator on over 25 departmental and industry-sponsored clinical trials and research investigations of rosacea, atopic dermatitis, psoriasis, lichen planus, and other dermatologic conditions. She served on the Michigan Medicine Research Board of Directors Clinical Trials Subcommittee, with the key task of helping the institution create a unified clinical research enterprise, and subsequently served as one of the inaugural Medical Directors of the Neurosciences and Sensory Clinical Trials Support Unit. Dr. Helfrich embraces her role as an educator, and has served as the Residency Program Director in Dermatology since January 2016. She has worked hard to optimize the clinical training and educational environment for residents within the program. She was recently elected to the American Professors of Dermatology Program Directors Steering Committee. She also serves on the Michigan Medicine Graduate Medical Education Committee (GMEC). In 2015, she was elected to Michigan Medicine’s League of Educational Excellence, which honors instructional faculty for their extraordinary contributions to teaching and inspiring the next generation of Michigan physicians and scientists.Dr. Helfrich is a Michigan native. She grew up in Grayling and attended Grayling High School. She graduated with a B.A. in Latin and Ancient History from Swarthmore College in Pennsylvania. She subsequently attended medical school at the University of Michigan Medical School, graduating in 2001. Dr. Helfrich completed her internship in internal medicine and her residency in dermatology at the University of Michigan. She joined the faculty at the University of Michigan Department of Dermatology in 2. Dr. Helfrich is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 52 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Rosacea, Graham-Little-Piccardi-Lassueur Syndrome, and Melanoma. Dr. Helfrich is board certified in Dermatology.

Dr. Frank Wang, MD is a board-certified Dermatologist. He graduated from Stanford University and received his medical degree from Cornell University Medical College. Dr. Wang served his internship at the University of Pittsburgh Medical Center, and went on to complete a Fellowship and his Dermatology Residency here at the University of Michigan. In 2010, Dr. Wang joined the faculty at the University of Michigan Department of Dermatology. His interests and expertise include general clinical dermatology, and clinical and basic science research in the area of skin aging. Dr. Wang is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Psoriasis, Actinic Keratosis, Pyoderma Gangrenosum, and Melanoma. Dr. Wang is board certified in Dermatology.

Dr. Cha is a faculty member in the University of Michigan Department of Dermatology. Her interests include general medical dermatology, melanoma, and skin procedures. She sees patients at the University of Michigan Domino's Farms Dermatology Clinic and at the Multidisciplinary Melanoma Clinic in the Cancer Center. In addition, Dr. Cha directs the Department of Dermatology's community outreach involvement with the Hope Clinic. Dr. Cha is a graduate of the University of Michigan Medical School and the Medical Scientist Training Program, through which she earned her medical degree and a PhD in the Department of Human Genetics. Dr. Cha joined the faculty of the University of Michigan Department of Dermatology in 2010, after competing her dermatology residency training. Dr. Cha is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Epidermoid Cyst, and Actinic Keratosis. Dr. Cha is board certified in Dermatology.

Joan Rindler is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Rindler is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Neurocutaneous Melanosis, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus.

Dr. Sruthi Renati is a board-certified dermatologist dedicated to providing comprehensive medical dermatology care for patients of all ages. She sees patients at our outpatient clinics located at Domino’s Farms, Northville Health Center, and the Taubman Center.Dr. Renati has a special interest in providing dermatology care for patients undergoing cancer treatment. She cares for patients experiencing skin-related side effects from cancer treatments such as chemotherapy, immunotherapy, and radiation therapy in the Oncodermatology clinic she leads.Dr. Renati received her medical degree from Harvard Medical School. She completed her dermatology residency at the University of Michigan Department of Dermatology, and she joined the dermatology faculty in August 2019. In addition to her clinical practice, she enjoys educating and mentoring medical students and dermatology residents. Dr. Renati is rated as an Experienced provider by MediFind in the treatment of Neurocutaneous Melanosis. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Actinic Keratosis, Warts, Sunburn, and Vulvectomy. Dr. Renati is board certified in Dermatology.

Timothy Vandenboom is a Dermatologist practicing medicine in Ypsilanti, Michigan. Dr. Vandenboom is rated as an Advanced provider by MediFind in the treatment of Neurocutaneous Melanosis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Actinic Keratosis, Syringocystadenoma Papilliferum, and Syringoma.